
# D15 — Monitoring & Drift Control Plan

## 1. Monitoring Objective

The monitoring framework is designed to detect structural, statistical,
performance, subgroup, explainability, workflow, and governance signals
without automatically modifying the model.

## 2. Monitoring Coverage

- Monitoring controls: 17
- Immediate monitoring domains: 11
- Outcome-dependent monitoring domains: 6
- Escalation triggers: 17

## 3. Quantitative Reference Principle

D14 locked-test rate estimates and uncertainty intervals are classified as
internal historical surveillance references.

They are not:

- production acceptance limits;
- clinical acceptability thresholds;
- external-validation criteria;
- evidence of clinical effectiveness; or
- automatic model-change triggers.

## 4. Statistical Signal Governance

A statistical signal does not automatically establish clinical materiality.

A single monitoring window does not establish persistent drift.

Persistent or material signals require authorized investigation and
governance review.

## 5. Outcome Maturity

Outcome-dependent performance controls are not assessable until sufficient
matured outcome evidence is available.

Insufficient evidence must not default to NORMAL.

## 6. Automated Change Prohibition

Monitoring does not automatically:

- retrain the model;
- recalibrate the model;
- change the operating threshold;
- alter preprocessing;
- introduce subgroup-specific thresholds; or
- authorize production deployment.

## 7. Deployment Status

Production deployment authorized: **FALSE**
